PubRank

Attila T Lorincz

Author PubWeight™ 37.25‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. J Natl Cancer Inst 2005 6.03
2 A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China. Lancet Oncol 2008 4.43
3 Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis. J Natl Cancer Inst 2003 3.08
4 A prospective study of high-grade cervical neoplasia risk among human papillomavirus-infected women. J Natl Cancer Inst 2002 1.83
5 A long-term prospective study of type-specific human papillomavirus infection and risk of cervical neoplasia among 20,000 women in the Portland Kaiser Cohort Study. Cancer Epidemiol Biomarkers Prev 2011 1.82
6 Clinical human papillomavirus detection forecasts cervical cancer risk in women over 18 years of follow-up. J Clin Oncol 2012 1.78
7 Absolute quantitation of DNA methylation of 28 candidate genes in prostate cancer using pyrosequencing. Dis Markers 2011 1.56
8 Identification of ZDHHC14 as a novel human tumour suppressor gene. J Pathol 2014 1.55
9 Elevated methylation of HPV16 DNA is associated with the development of high grade cervical intraepithelial neoplasia. Int J Cancer 2012 1.44
10 Methylation of HPV18, HPV31, and HPV45 genomes and cervical intraepithelial neoplasia grade 3. J Natl Cancer Inst 2012 1.38
11 New technologies and procedures for cervical cancer screening. Vaccine 2012 1.29
12 Results of human papillomavirus DNA testing with the hybrid capture 2 assay are reproducible. J Clin Microbiol 2002 1.14
13 Comparison between prototype hybrid capture 3 and hybrid capture 2 human papillomavirus DNA assays for detection of high-grade cervical intraepithelial neoplasia and cancer. J Clin Microbiol 2003 1.05
14 Absolute risk of a subsequent abnormal pap among oncogenic human papillomavirus DNA-positive, cytologically negative women. Cancer 2002 1.03
15 Semiquantitative human papillomavirus type 16 viral load and the prospective risk of cervical precancer and cancer. Cancer Epidemiol Biomarkers Prev 2005 0.97
16 Adjunctive human papillomavirus testing in the 2-year follow-up of women with low-grade cervical cytologic abnormalities: a randomized trial and economic evaluation. Arch Pathol Lab Med 2003 0.91
17 Comparison of Digene hybrid capture 2 and conventional culture for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in cervical specimens. J Clin Microbiol 2002 0.88
18 A DNA methylation classifier of cervical precancer based on human papillomavirus and human genes. Int J Cancer 2014 0.88
19 Methylation of viral and host genes and severity of cervical lesions associated with human papillomavirus type 16. Int J Cancer 2014 0.88
20 Mouthwash as a low-cost and safe specimen transport medium for human papillomavirus DNA testing of cervicovaginal specimens. Cancer Epidemiol Biomarkers Prev 2007 0.87
21 Quantitative DNA methylation and recurrence of breast cancer: a study of 30 candidate genes. Cancer Biomark 2012 0.83
22 DNA methylation of PITX2 predicts poor survival in men with prostate cancer. Biomark Med 2014 0.82
23 HPV33 DNA methylation measurement improves cervical pre-cancer risk estimation of an HPV16, HPV18, HPV31 and \textit{EPB41L3} methylation classifier. Cancer Biomark 2015 0.80
24 Comparison of two signal-amplification DNA tests for high-risk HPV as an aid to colposcopy. J Reprod Med 2002 0.77
25 A novel filtration-based processing method of liquid cytology specimens for human papillomavirus DNA testing by hybrid capture II. Am J Clin Pathol 2005 0.75